Global stocks were mixed Tuesday ahead of the release of the U.S. government's bank stress test results out later in the week as reports claim up to 10 banks will need to raise more capital. Experts tell CNBC that until the banks' problems are resolved, the pace of the economic recovery is likely to be hindered.
Bank Deleveraging Still a Long Way to Go
David Roche, global strategist at Independent Strategy, warns that banks' debt overhang will restrict the pace of any subsequent U.S. economic recovery. He speaks to CNBC's Martin Soong.
The Trouble with US Stress Tests
There are some points about the U.S. stress tests that are worthwhile questioning, believes Par Magnusson, senior analyst at Danske Bank. He outlines where the trouble lies in the stress tests.
PPIP a Good Idea
Wilbur Ross, chairman & CEO of WL Ross & Co., plans to invest in U.S. banks' toxic assets under the PPIP (public private investment program for Legacy Assets). He says the PPIP's terms, such as low interest rate financing, will offer investors a good rate of return.
US Automakers Won't Go to the Wall
The U.S. won't let Chrysler go to the wall as it is a significant part of industrial America, remarked David Roche, global strategist at Independent Strategy. He assesses the troubled auto sector.
US Not Heading For Lush Green Meadows
David Roche, global strategist at Independent Strategy, does not buy the "green shoots" story, as the U.S. is still bearing the consequences of excess leverage and overspending among consumers.
US Unlikely to See Hyperinflation
Inflation will certainly return to the U.S. but not hyperinflation, foresees David Roche, global strategist at Independent Strategy.
The Deflationary Debate
David Roche, global strategist at Independent Strategy disagrees with a viewer email suggesting the world economy will be in a deflationary environment.
China's main challenge is how it plans to switch from a factory-led economy to a domestic consumer-led economy, notes David Roche, global strategist at Independent Strategy.
WHO's Credibility At Risk
If the WHO raises the swine flu alert to level 6, its highest rating, it could undermine the organization's credibility, says Scott Rosenstein, analyst at the Eurasia Group.